These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Sphingosine-1-phosphate stimulates human Caco-2 intestinal epithelial proliferation via p38 activation and activates ERK by an independent mechanism. Thamilselvan V, Li W, Sumpio BE, Basson MD. In Vitro Cell Dev Biol Anim; 2002 Apr; 38(4):246-53. PubMed ID: 12197778 [Abstract] [Full Text] [Related]
23. Activation of phosphatidylinositol 3-kinase and extracellular signal-regulated kinase is required for glial cell line-derived neurotrophic factor-induced migration and invasion of pancreatic carcinoma cells. Veit C, Genze F, Menke A, Hoeffert S, Gress TM, Gierschik P, Giehl K. Cancer Res; 2004 Aug 01; 64(15):5291-300. PubMed ID: 15289335 [Abstract] [Full Text] [Related]
25. The roles of ERK1/2 and p38 MAP kinases in the preventive mechanisms of mushroom Phellinus linteus against the inhibition of gap junctional intercellular communication by hydrogen peroxide. Cho JH, Cho SD, Hu H, Kim SH, Lee SK, Lee YS, Kang KS. Carcinogenesis; 2002 Jul 01; 23(7):1163-9. PubMed ID: 12117774 [Abstract] [Full Text] [Related]
26. PKC, p42/44 MAPK and p38 MAPK regulate hepatocyte growth factor secretion from human astrocytoma cells. Chattopadhyay N, Tfelt-Hansen J, Brown EM. Brain Res Mol Brain Res; 2002 Jun 15; 102(1-2):73-82. PubMed ID: 12191496 [Abstract] [Full Text] [Related]
27. Modulation of renal epithelial barrier function by mitogen-activated protein kinases (MAPKs): mechanism of cyclosporine A-induced increase in transepithelial resistance. Kiely B, Feldman G, Ryan MP. Kidney Int; 2003 Mar 15; 63(3):908-16. PubMed ID: 12631071 [Abstract] [Full Text] [Related]
28. Interferon-alpha2b reduces phosphorylation and activity of MEK and ERK through a Ras/Raf-independent mechanism. Romerio F, Riva A, Zella D. Br J Cancer; 2000 Aug 15; 83(4):532-8. PubMed ID: 10945503 [Abstract] [Full Text] [Related]
29. ERK signaling pathway is involved in p15INK4b/p16INK4a expression and HepG2 growth inhibition triggered by TPA and Saikosaponin a. Wen-Sheng W. Oncogene; 2003 Feb 20; 22(7):955-63. PubMed ID: 12592382 [Abstract] [Full Text] [Related]
30. Specific inhibition of basal mitogen-activated protein kinases and phosphatidylinositol 3 kinase activities in leukemia cells: a possible therapeutic role for the kinase inhibitors. Champelovier P, El Atifi M, Pautre V, Rostaing B, Berger F, Seigneurin D. Exp Hematol; 2008 Jan 20; 36(1):28-36. PubMed ID: 17949889 [Abstract] [Full Text] [Related]
31. Anti-apoptotic effect of quercetin: intervention in the JNK- and ERK-mediated apoptotic pathways. Ishikawa Y, Kitamura M. Kidney Int; 2000 Sep 20; 58(3):1078-87. PubMed ID: 10972672 [Abstract] [Full Text] [Related]
32. Activation of p44/p42 MAP kinase in striatal neurons via kainate receptors and PI3 kinase. Fuller G, Veitch K, Ho LK, Cruise L, Morris BJ. Brain Res Mol Brain Res; 2001 Apr 18; 89(1-2):126-32. PubMed ID: 11311983 [Abstract] [Full Text] [Related]
33. p38 mitogen-activated protein kinase regulates growth factor-induced mitogenesis of rat pulmonary myofibroblasts. Rice AB, Ingram JL, Bonner JC. Am J Respir Cell Mol Biol; 2002 Dec 18; 27(6):759-65. PubMed ID: 12444037 [Abstract] [Full Text] [Related]
34. Activation of p38 MAP kinase and ERK are required for ultraviolet-B induced c-fos gene expression in human keratinocytes. Chen W, Bowden GT. Oncogene; 1999 Dec 09; 18(52):7469-76. PubMed ID: 10602506 [Abstract] [Full Text] [Related]
35. Specific role of the extracellular signal-regulated kinase pathway in angiotensin II-induced cardiac hypertrophy in vitro. Aoki H, Richmond M, Izumo S, Sadoshima J. Biochem J; 2000 Apr 01; 347 Pt 1(Pt 1):275-84. PubMed ID: 10727428 [Abstract] [Full Text] [Related]
36. Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53. Bacus SS, Gudkov AV, Lowe M, Lyass L, Yung Y, Komarov AP, Keyomarsi K, Yarden Y, Seger R. Oncogene; 2001 Jan 11; 20(2):147-55. PubMed ID: 11313944 [Abstract] [Full Text] [Related]
37. The MAP kinase inhibitors, PD098059, UO126 and SB203580, inhibit IL-1beta-dependent PGE(2) release via mechanistically distinct processes. Newton R, Cambridge L, Hart LA, Stevens DA, Lindsay MA, Barnes PJ. Br J Pharmacol; 2000 Jul 11; 130(6):1353-61. PubMed ID: 10903976 [Abstract] [Full Text] [Related]
38. Multiple anticancer effects of blocking MEK-ERK signaling in hepatocellular carcinoma. Wiesenauer CA, Yip-Schneider MT, Wang Y, Schmidt CM. J Am Coll Surg; 2004 Mar 11; 198(3):410-21. PubMed ID: 14992744 [Abstract] [Full Text] [Related]
39. Enhancement of peripheral benzodiazepine receptor ligand-induced apoptosis and cell cycle arrest of esophageal cancer cells by simultaneous inhibition of MAPK/ERK kinase. Sutter AP, Maaser K, Gerst B, Krahn A, Zeitz M, Scherübl H. Biochem Pharmacol; 2004 May 01; 67(9):1701-10. PubMed ID: 15081869 [Abstract] [Full Text] [Related]
40. U0126 and PD98059, specific inhibitors of MEK, accelerate differentiation of RAW264.7 cells into osteoclast-like cells. Hotokezaka H, Sakai E, Kanaoka K, Saito K, Matsuo K, Kitaura H, Yoshida N, Nakayama K. J Biol Chem; 2002 Dec 06; 277(49):47366-72. PubMed ID: 12237315 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]